Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada

Published:2023-10 Issue: Volume: Page:
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Cheung Winson Y.,Samimi Setareh,Ma Kim,Knight Gregory John,Kassam Shaqil,Colwell Bruce,Beaudoin Annie,Vincent Mark David,Trinkaus Mateya,Filion Alain,Marquis Katerine,Karachiwala Hatim,Asmis Timothy,Sideris Lucas,Wani Rajvi J.,Ngan Elaine,Inam Naila,Du Yinhao,Nunez Leyla,Eberg Maria,Alemayehu Mistre,Meyer Pierre-Francois,Mancini Johanna,Cirone Morris Carlye^ORCID

Funder

Amgen

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference33 articles.

1. WHO-IAfRo C. Colorectal cancer fact sheet. https://gco.iarc.fr/today/data/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf .(accessed on 10 October 2023).

2. Projected estimates of cancer in Canada in 2022;Brenner;CMAJ,2022

3. Clinical management of metastatic colorectal cancer in the era of precision medicine;Ciardiello;CA Cancer J Clin,2022

4. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

5. Limited H-LR. AVASTINⓇ bevacizumab for injection Product Monograph. 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP